...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Probability of Phase 3 trial success

Keeping in mind all the pitfalls that Bear pointed out I find the data in Table 3 encouraging. Trials that have Biomarkers, Cardiovascular, 85.7% POS(Probability Of Success). Diabetic, recent ACS, Low HDL, High CRP. Let's hope the trial design works as well as most others with biomarkers.

tada

Share
New Message
Please login to post a reply